16 jul 2012 ano - FDA Approves Truvada

Descrição:

On July 16, 2012, the U.S. Food and Drug Administration (FDA) approved the use of Truvada® (a fixed dose combination of emtricitabine/tenofovir disoproxil fumarate) as a pre-exposure prophylaxis (PrEP) for HIV-negative individuals who are at high risk of acquiring HIV.

Adicionado na linha do tempo:

Data: